Clinical trial with hycanthone in Schistosomiasis mansoni in Surinam.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000871:Anthelmintics / Q000009:adverse effects / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D002648:Child; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005069:Evaluation Studies as Topic; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D005260:Female; D006261:Headache / Q000139:chemically induced; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D008154:Lucanthone; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010146:Pain / Q000139:chemically induced; D012552:Schistosomiasis / Q000517:prevention & control*; D013532:Suriname; D014330:Tropical Medicine; D014717:Vertigo / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D000871:Anthelmintics; D004338:Drug Combinations; D006634:Histamine H1 Antagonists; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D008154:Lucanthone